HDL and LDL cholesterol [[electronic resource] ] : physiology and clinical significance / / Irwin S. Pagano and Nathan B. Strait, editors |
Pubbl/distr/stampa | New York, : Nova Biomedical Books, c2009 |
Descrizione fisica | 1 online resource (242 p.) |
Disciplina | 572/.68 |
Altri autori (Persone) |
PaganoIrwin S
StraitNathan B |
Collana | Biochemistry research trends series |
Soggetto topico |
High density lipoproteins - Physiological effect
High density lipoproteins - Pathophysiology Low density lipoproteins - Physiological effect Low density lipoproteins - Pathophysiology |
Soggetto genere / forma | Electronic books. |
ISBN | 1-60876-728-0 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910452733203321 |
New York, : Nova Biomedical Books, c2009 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
HDL and LDL cholesterol [[electronic resource] ] : physiology and clinical significance / / Irwin S. Pagano and Nathan B. Strait, editors |
Pubbl/distr/stampa | New York, : Nova Biomedical Books, c2009 |
Descrizione fisica | 1 online resource (242 p.) |
Disciplina | 572/.68 |
Altri autori (Persone) |
PaganoIrwin S
StraitNathan B |
Collana | Biochemistry research trends series |
Soggetto topico |
High density lipoproteins - Physiological effect
High density lipoproteins - Pathophysiology Low density lipoproteins - Physiological effect Low density lipoproteins - Pathophysiology |
ISBN | 1-60876-728-0 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Cost-effectiveness of pharmacological therapies to reduce LDL-cholesterol levels / Pedro Plans-Rubió -- Mechanisms for oxidative modification of LDL by cigarette smoking : new insight into potential implications for atherosclerosis / Yu Yamaguchi, Jun Haginaka, and Masaru Kunitomo -- Selective LDL apheresis reduced on plasma concentrations of adhesion molecules / Kouichi Utsumi, Kae Ueda, and Yasuo Katayama -- Pleiotropic effects of atorvastatin on vascular injury in diabetes / Sho-ichi Yamagishi ... [et al.] -- Antibodies to oxidatively modified LDL and atherosclerosis / Ulrike Resch, Franz Tatzber -- Overview of longevity-associated mitochondrial DNA 5178 C/A polymorphism and a discussion of its modulation of the effects of habitual smoking on serum total and LDL cholesterol levels in middle-aged Japanese men / Akatsuki Kokaze ... [et al.] -- Cholesterol-HDL levels and functionality of the HDL particle, its anti-inflammatory/antioxidant properties / M. Fitó ... [et al.] -- The role of HDL-associated enzymes in bovine reproduction / Romana Turk -- HDL physicochemical characteristics as determinants of their plasma concentrations : what we have learned from thiazolidinediones / Oscar Pérez-Méndez ... [et al.] -- High-density lipoproteins and coronary heart disease HDLs : a heterogeneous and multi-functional lipoprotein class / Bela F. Asztalos and Katalin V. Horvath. |
Record Nr. | UNINA-9910779646903321 |
New York, : Nova Biomedical Books, c2009 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
HDL and LDL cholesterol : physiology and clinical significance / / Irwin S. Pagano and Nathan B. Strait, editors |
Edizione | [1st ed.] |
Pubbl/distr/stampa | New York, : Nova Biomedical Books, c2009 |
Descrizione fisica | 1 online resource (242 p.) |
Disciplina | 572/.68 |
Altri autori (Persone) |
PaganoIrwin S
StraitNathan B |
Collana | Biochemistry research trends series |
Soggetto topico |
High density lipoproteins - Physiological effect
High density lipoproteins - Pathophysiology Low density lipoproteins - Physiological effect Low density lipoproteins - Pathophysiology |
ISBN | 1-60876-728-0 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Cost-effectiveness of pharmacological therapies to reduce LDL-cholesterol levels / Pedro Plans-Rubió -- Mechanisms for oxidative modification of LDL by cigarette smoking : new insight into potential implications for atherosclerosis / Yu Yamaguchi, Jun Haginaka, and Masaru Kunitomo -- Selective LDL apheresis reduced on plasma concentrations of adhesion molecules / Kouichi Utsumi, Kae Ueda, and Yasuo Katayama -- Pleiotropic effects of atorvastatin on vascular injury in diabetes / Sho-ichi Yamagishi ... [et al.] -- Antibodies to oxidatively modified LDL and atherosclerosis / Ulrike Resch, Franz Tatzber -- Overview of longevity-associated mitochondrial DNA 5178 C/A polymorphism and a discussion of its modulation of the effects of habitual smoking on serum total and LDL cholesterol levels in middle-aged Japanese men / Akatsuki Kokaze ... [et al.] -- Cholesterol-HDL levels and functionality of the HDL particle, its anti-inflammatory/antioxidant properties / M. Fitó ... [et al.] -- The role of HDL-associated enzymes in bovine reproduction / Romana Turk -- HDL physicochemical characteristics as determinants of their plasma concentrations : what we have learned from thiazolidinediones / Oscar Pérez-Méndez ... [et al.] -- High-density lipoproteins and coronary heart disease HDLs : a heterogeneous and multi-functional lipoprotein class / Bela F. Asztalos and Katalin V. Horvath. |
Record Nr. | UNINA-9910810128703321 |
New York, : Nova Biomedical Books, c2009 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
High-density lipoproteins : from basic biology to clinical aspects / / edited by Christopher J. Fielding |
Pubbl/distr/stampa | Weinheim, [Germany] : , : Wiley-VCH Verlag GmbH & Co. KGaA, , 2007 |
Descrizione fisica | 1 online resource (555 p.) |
Disciplina |
572.68
572/.68 |
Soggetto topico |
Lipoproteins
High density lipoproteins |
Soggetto genere / forma | Electronic books. |
ISBN |
1-282-02162-1
9786612021626 3-527-62517-8 3-527-62518-6 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
High-Density Lipoproteins; Contents; Preface; List of Contributors; I HDL Structure; 1 Apolipoprotein A-I Structure; 1.1 Introduction and Perspective; 1.2 Lipid-Free ApoA-I; 1.3 The Role of Protein Structure in ApoA-I Function; 1.4 Full-Length ApoA-I X-Ray Structure; 1.5 Apolipoprotein A-I Structure - Lipid-Bound State; 1.6 Structural Studies of ApoA-I on Discoidal Nascent HDL; 1.7 Hinge Domain; 1.8 Computer Models; 1.9 Spherical HDL; 1.10 Future Directions; 1.11 Acknowledgments; 2 Apolipoprotein A-II; 2.1 Apolipoprotein A-II Structure and Plasma Level Regulation
2.1.1 Structural Organization and Transcriptional Regulation of the Gene2.1.2 ApoA-II Mutations and Polymorphisms; 2.1.3 Protein Structure, Synthesis, Secretion, and Metabolism; 2.1.4 Other Determinants of ApoA-II Levels; 2.2 Pathophysiological Role of ApoA-II; 2.2.1 On HDL Metabolism; 2.2.1.1 HDL Remodeling; 2.2.1.2 Reverse Cholesterol Transport Function; 2.2.1.3 Antioxidant and Anti-inflammatory Effects; 2.2.2 Role of ApoA-II in Triglyceride and Glucose Metabolism; 2.2.2.1 Triglyceride and Free Fatty Acid (FFA) Metabolism; 2.2.2.2 Glucose Homeostasis 2.2.2.3 Role of ApoA-II in Dyslipidemia and Type 2 Diabetes Mellitus2.2.3 ApoA-II in Atherogenesis; 2.3 Acknowledgments; 3 Apolipoprotein E and Reverse Cholesterol Transport: The Role of Recycling in Plasma and Intracellular Lipid Trafficking; 3.1 Introduction; 3.2 Role of ApoE in Triglyceride-Rich Lipoprotein Metabolism; 3.2.1 ApoE and Lipoprotein Assembly and Secretion; 3.2.2 ApoE and Lipoprotein Processing and Catabolism; 3.2.3 ApoE and Lipoprotein Uptake; 3.3 Role of ApoE in HDL Metabolism; 3.3.1 HDL Formation and Maturation; 3.3.2 Cholesterol Efflux and RCT 3.3.3 Roles of apoE in RCT and HDL Metabolism3.3.4 Critical Roles for ApoE and SR-BI in RCT; 3.4 ApoE and Recycling; 3.4.1 Evidence for apoE Recycling; 3.4.2 Regulation of ApoE recycling; 3.4.3 ApoE Recycling and Cholesterol Efflux; 3.4.4 Form of Recycled ApoE; 3.4.5 ApoE Recycling: Relevance to Atherosclerosis; 3.5 Summary; 4 ApoM - A Novel Apolipoprotein with Antiatherogenic Properties; 4.1 Introduction; 4.2 Cloning and Characterization of Human ApoM; 4.3 Gene Location and Amino Acid Sequence of ApoM; 4.4 Protein Structure of ApoM; 4.5 Distribution of ApoM in Plasma Lipoproteins 4.6 Tissue Distribution and Cellular Expression of ApoM4.7 Putative Functions of ApoM; 4.8 Regulation of ApoM; 4.9 Hormonal Regulation of ApoM; 4.10 Clinical Observations; 4.11 Conclusions and Perspectives; II HDL Plasma Metabolic Factors; 5 ATP Binding Cassette Transporters; 5.1 The Family of ABC Transporters - General Features; 5.2 ABC Transporters and Lipid Transport; 5.3 The ABCA Subfamily and the Handling of Excess Lipids; 5.3.1 ABCA1; 5.3.1.1 ABCA1 Expression and its Control; 5.3.1.2 Structural Considerations 5.3.1.3 ABCA1 and Cellular Effluxes of Phospholipid and Cholesterol - Facts and Speculation |
Record Nr. | UNINA-9910144407203321 |
Weinheim, [Germany] : , : Wiley-VCH Verlag GmbH & Co. KGaA, , 2007 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
High-density lipoproteins : from basic biology to clinical aspects / / edited by Christopher J. Fielding |
Pubbl/distr/stampa | Weinheim, [Germany] : , : Wiley-VCH Verlag GmbH & Co. KGaA, , 2007 |
Descrizione fisica | 1 online resource (555 p.) |
Disciplina |
572.68
572/.68 |
Soggetto topico |
Lipoproteins
High density lipoproteins |
ISBN |
1-282-02162-1
9786612021626 3-527-62517-8 3-527-62518-6 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
High-Density Lipoproteins; Contents; Preface; List of Contributors; I HDL Structure; 1 Apolipoprotein A-I Structure; 1.1 Introduction and Perspective; 1.2 Lipid-Free ApoA-I; 1.3 The Role of Protein Structure in ApoA-I Function; 1.4 Full-Length ApoA-I X-Ray Structure; 1.5 Apolipoprotein A-I Structure - Lipid-Bound State; 1.6 Structural Studies of ApoA-I on Discoidal Nascent HDL; 1.7 Hinge Domain; 1.8 Computer Models; 1.9 Spherical HDL; 1.10 Future Directions; 1.11 Acknowledgments; 2 Apolipoprotein A-II; 2.1 Apolipoprotein A-II Structure and Plasma Level Regulation
2.1.1 Structural Organization and Transcriptional Regulation of the Gene2.1.2 ApoA-II Mutations and Polymorphisms; 2.1.3 Protein Structure, Synthesis, Secretion, and Metabolism; 2.1.4 Other Determinants of ApoA-II Levels; 2.2 Pathophysiological Role of ApoA-II; 2.2.1 On HDL Metabolism; 2.2.1.1 HDL Remodeling; 2.2.1.2 Reverse Cholesterol Transport Function; 2.2.1.3 Antioxidant and Anti-inflammatory Effects; 2.2.2 Role of ApoA-II in Triglyceride and Glucose Metabolism; 2.2.2.1 Triglyceride and Free Fatty Acid (FFA) Metabolism; 2.2.2.2 Glucose Homeostasis 2.2.2.3 Role of ApoA-II in Dyslipidemia and Type 2 Diabetes Mellitus2.2.3 ApoA-II in Atherogenesis; 2.3 Acknowledgments; 3 Apolipoprotein E and Reverse Cholesterol Transport: The Role of Recycling in Plasma and Intracellular Lipid Trafficking; 3.1 Introduction; 3.2 Role of ApoE in Triglyceride-Rich Lipoprotein Metabolism; 3.2.1 ApoE and Lipoprotein Assembly and Secretion; 3.2.2 ApoE and Lipoprotein Processing and Catabolism; 3.2.3 ApoE and Lipoprotein Uptake; 3.3 Role of ApoE in HDL Metabolism; 3.3.1 HDL Formation and Maturation; 3.3.2 Cholesterol Efflux and RCT 3.3.3 Roles of apoE in RCT and HDL Metabolism3.3.4 Critical Roles for ApoE and SR-BI in RCT; 3.4 ApoE and Recycling; 3.4.1 Evidence for apoE Recycling; 3.4.2 Regulation of ApoE recycling; 3.4.3 ApoE Recycling and Cholesterol Efflux; 3.4.4 Form of Recycled ApoE; 3.4.5 ApoE Recycling: Relevance to Atherosclerosis; 3.5 Summary; 4 ApoM - A Novel Apolipoprotein with Antiatherogenic Properties; 4.1 Introduction; 4.2 Cloning and Characterization of Human ApoM; 4.3 Gene Location and Amino Acid Sequence of ApoM; 4.4 Protein Structure of ApoM; 4.5 Distribution of ApoM in Plasma Lipoproteins 4.6 Tissue Distribution and Cellular Expression of ApoM4.7 Putative Functions of ApoM; 4.8 Regulation of ApoM; 4.9 Hormonal Regulation of ApoM; 4.10 Clinical Observations; 4.11 Conclusions and Perspectives; II HDL Plasma Metabolic Factors; 5 ATP Binding Cassette Transporters; 5.1 The Family of ABC Transporters - General Features; 5.2 ABC Transporters and Lipid Transport; 5.3 The ABCA Subfamily and the Handling of Excess Lipids; 5.3.1 ABCA1; 5.3.1.1 ABCA1 Expression and its Control; 5.3.1.2 Structural Considerations 5.3.1.3 ABCA1 and Cellular Effluxes of Phospholipid and Cholesterol - Facts and Speculation |
Record Nr. | UNINA-9910831198103321 |
Weinheim, [Germany] : , : Wiley-VCH Verlag GmbH & Co. KGaA, , 2007 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Prominin-1 (CD133) : new insights on stem & cancer stem cell biology / / Denis Corbeil, editor |
Edizione | [1st ed. 2013.] |
Pubbl/distr/stampa | New York, : Springer, c2013 |
Descrizione fisica | 1 online resource (254 p.) |
Disciplina | 572/.68 |
Altri autori (Persone) | CorbeilDenis |
Collana | Advances in experimental medicine and biology |
Soggetto topico |
Glycoproteins
Stem cells |
ISBN |
1-4614-5894-3
1-283-91177-9 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Preface -- Prominin-1 (CD133): Molecular and Cellular Features Across Species -- Prominin-2 and Other Relatives of CD133 -- Prominin-1–containing Membrane Vesicles: Origins, Formation and Utility -- Prominent Role of Prominin in the Retina -- Gene Regulation of Prominin-1 (CD133) in Normal and Cancerous Tissues -- Prominin-1 (CD133) and the Cell Biology of Neural Progenitors and Their Progeny -- CD133–Positive Hematopoietic Stem Cells: From Biology to Medicine -- New Insights into the Renal Progenitor Cells and Kidney Diseases by Studying CD133 -- CD133 Expression Strongly Correlates with the Phenotype of Very Small Embryonic/Epiblast-like Stem Cells -- New Insights into the CD133 (Prominin-1) Expression in Mouse and Human Colon Cancer Cells -- Prominin-1 (CD133) Expression in the Prostate and Prostate Cancer: A Marker for Quiescent Stem Cells -- Prominin-1 (CD133) Reveals New Faces of Pancreatic Progenitor Cells and Cancer Stem Cells: Current Knowledge and Therapeutic Perspectives -- Prominin-1 (CD133) and Metastatic Melanoma: Current Knowledge and Therapeutic Perspectives -- CD133-Positive Cells for Cardiac Stem Cell Therapy: Current Status and Outlook -- CD133+ Cells for the Treatment of Degenerative Diseases: Update and Perspectives -- Index. |
Record Nr. | UNINA-9910437611603321 |
New York, : Springer, c2013 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|